Clinical and Patient Overview

Molecular Insight is committed to improving patient care for the detection, treatment, and management of prostate cancer. Prospective patients or their physicians who may be interested in participating in these clinical trials may wish to refer to information on these pages or contact:

Clinical Department
Molecular Insight Pharmaceuticals, Inc.
Telephone: (617) 492-5554

Oncology Trials

• ^99mTc-MIP-1404 for Imaging Prostate Cancer: Phase 1 Clinical Study to Assess the Image Quality of a Simplified Kit Formulation Compared to a Multi-step Preparation of ^99mTc-MIP-1404
• Pilot Study of ^99mTc-MIP-1404 SPECT/CT Imaging in Men with Prostate Cancer Undergoing Prostatectomy and/or Pelvic Lymph Node Dissection
• Phase 1 Pilot Study of ^99mTc-MIP-1404 SPECT/CT Imaging to Histology in Men
  with Prostate Cancer
• A Phase 2 Diagnostic Imaging Study with ^99mTc-MIP-1404 in Men With High-Risk Prostate Cancer Scheduled for Radical Prostatectomy (RP) and Extended Pelvic-Lymph Node Dissection (EPLND) Compared to Histopathology